Opportunity Information: Apply for RFA CA 18 016
The NCI Community Oncology Research Program (NCORP) Community Sites funding opportunity (RFA-CA-18-016) is a National Cancer Institute cooperative agreement (UG1) meant to support institutions and organizations that can function as community-based clinical research hubs. The central purpose is to expand the reach of NCI-supported research beyond large academic cancer centers and into real-world community settings where many patients actually receive care. Under this program, selected awardees serve as "Community Sites" within the broader NCORP network and are expected to enroll, or accrue, a diverse mix of patients and participants into NCI-approved studies. Because the mechanism is a cooperative agreement, recipients do not operate in isolation; they work closely with NCI and NCORP leadership, following program standards and participating in coordinated network activities.
NCORP itself is described as a community-based research network that designs and conducts clinical trials and other human subjects studies across the cancer continuum. The research portfolio emphasized in this announcement includes cancer control, prevention, screening, and care delivery research, along with quality-of-life studies that may be embedded within treatment trials. A key theme is practical, patient-centered research that can be conducted where patients live and receive routine care, improving both the relevance of findings and the ability to translate results into everyday practice. In addition to these non-treatment domains, NCORP Community Sites also help broaden access to treatment and imaging trials conducted through the National Clinical Trials Network (NCTN), which is the NCI-supported national system for large, multi-site oncology treatment trials.
A major priority of the opportunity is equitable participation and intentional inclusion of populations that have historically been underrepresented in clinical research. The FOA highlights the need to incorporate the needs of children, adolescents and young adults (AYAs), and older adults, as well as racial and ethnic minorities, sexual and gender minorities, and rural residents. Community Sites are expected not only to enroll participants from these groups, but also to take concrete steps that enhance participation, which implies having recruitment strategies, community partnerships, culturally competent processes, and operational practices that reduce barriers to enrollment and retention. Another explicit emphasis is integrating cancer disparities research within the community network, meaning the program is not only focused on who gets enrolled, but also on generating knowledge about disparities and testing interventions that can narrow gaps in prevention, care delivery, outcomes, and survivorship.
Structurally, this FOA covers only one part of a three-part NCORP ecosystem. NCORP is organized into (1) NCORP Research Bases, which design and lead studies; (2) NCORP Community Sites, which are the primary community enrollment and implementation arm covered here; and (3) NCORP Minority/Underserved Community Sites, which are supported under a separate FOA and are tailored to communities with substantial minority and underserved populations. Under this Community Sites announcement, the role is largely to implement and accrue participants to studies that are designed by NCORP Research Bases, as well as to enroll patients onto appropriate NCTN treatment and imaging trials. In practice, this means Community Sites must maintain the staff, regulatory readiness, clinical workflow integration, and data quality capabilities required to open trials, consent participants, deliver protocol-directed care or interventions, and report study data reliably.
Eligibility is broad and includes many types of organizations capable of operating clinical research programs in community settings. Eligible applicants listed include state, county, and local governments; special district governments; independent school districts; public and state-controlled and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with and without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities as permitted by the FOA’s additional eligibility language. The sponsoring agency is the U.S. Department of Health and Human Services through the National Institutes of Health, specifically the National Cancer Institute. The FOA anticipated about 40 awards. An "Award Ceiling" value is shown as 0 in the provided data, which typically indicates the ceiling was not specified in that summary field rather than implying no funding; applicants generally must consult the full FOA text for budget expectations, allowable costs, and any limits or justifications required.
Finally, the timing details in the provided record show the opportunity was created on June 13, 2018, with an original closing date of August 31, 2018. Overall, the announcement is aimed at building and sustaining a nationwide community-based oncology research infrastructure that can run high-quality, NCI-aligned studies, increase access to trials and evidence generation in everyday care settings, and directly address participation gaps and cancer disparities through intentional, network-driven community research.Apply for RFA CA 18 016
- The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394, 93.395, 93.399.
- This funding opportunity was created on Jun 13, 2018.
- Applicants must submit their applications by Aug 31, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 40 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NCI NCORP Community Sites (RFA-CA-18-016, UG1)
1) What is the NCORP Community Sites funding opportunity (RFA-CA-18-016)?
This opportunity is a National Cancer Institute (NCI) cooperative agreement (UG1) that supports institutions and organizations that can serve as community-based clinical research hubs. Awardees function as NCORP "Community Sites" within a national network and help bring NCI-supported research into real-world community care settings.
2) What is the main purpose of funding NCORP Community Sites?
The central purpose is to expand the reach of NCI-supported research beyond large academic cancer centers and into community settings where many patients actually receive care. Community Sites are expected to enroll (accrue) a diverse mix of participants into NCI-approved studies and help translate research into everyday practice.
3) What does it mean that this award uses a cooperative agreement (UG1) mechanism?
A cooperative agreement means recipients do not operate independently. Community Sites work closely with NCI and NCORP leadership, follow program standards, and participate in coordinated network activities as part of a larger system.
4) What is NCORP, in plain language?
NCORP is a community-based research network that designs and conducts clinical trials and other human subjects studies across the cancer continuum. It is structured to support research participation and study implementation in the places where patients live and receive routine care.
5) What types of research are emphasized in this announcement?
The research portfolio emphasized includes cancer control, prevention, screening, and care delivery research, as well as quality-of-life studies that may be embedded within treatment trials. The emphasis is on practical, patient-centered research suitable for community settings.
6) Does this opportunity include treatment trials?
Yes. While the announcement emphasizes non-treatment domains (such as prevention, screening, and care delivery research), NCORP Community Sites also help broaden access to treatment and imaging trials conducted through the National Clinical Trials Network (NCTN).
7) What is the National Clinical Trials Network (NCTN) and how does it relate to this opportunity?
NCTN is the NCI-supported national system for large, multi-site oncology treatment trials. NCORP Community Sites help enroll patients onto appropriate NCTN treatment and imaging trials, expanding access in community settings.
8) What are NCORP Community Sites expected to do day-to-day?
Community Sites are expected to implement studies approved within the network and accrue participants to those studies. In practice, this includes maintaining staff and operational capabilities to open trials, obtain consent, integrate research into clinical workflows, deliver protocol-directed care or interventions when applicable, and report study data reliably while meeting regulatory and quality expectations.
9) Who designs the studies that Community Sites implement?
Under the NCORP structure described, studies are designed and led by NCORP Research Bases. Community Sites primarily implement those studies and enroll participants, rather than serving as the main study-design entities under this specific announcement.
10) How does this FOA fit into the broader NCORP program structure?
This FOA covers only one part of a three-part NCORP ecosystem: (1) NCORP Research Bases (design and lead studies), (2) NCORP Community Sites (community enrollment and implementation arm covered here), and (3) NCORP Minority/Underserved Community Sites (supported under a separate FOA tailored to communities with substantial minority and underserved populations).
11) Is there a separate funding opportunity for Minority/Underserved Community Sites?
Yes. The information provided states that NCORP Minority/Underserved Community Sites are supported under a separate FOA and are tailored to communities with substantial minority and underserved populations.
12) What is the emphasis on equitable participation and inclusion?
A major priority is intentional inclusion of populations historically underrepresented in clinical research. The announcement highlights incorporating the needs of children, adolescents and young adults (AYAs), and older adults, as well as racial and ethnic minorities, sexual and gender minorities, and rural residents.
13) Are Community Sites only expected to enroll diverse participants, or also to change how they recruit and retain participants?
They are expected to do both. The information provided emphasizes not only enrolling participants from historically underrepresented groups, but also taking concrete steps to enhance participation. This implies having recruitment strategies, community partnerships, culturally competent processes, and operational practices that reduce barriers to enrollment and retention.
14) What does the FOA say about cancer disparities research?
Another explicit emphasis is integrating cancer disparities research within the community network. This indicates the program is focused not only on who gets enrolled, but also on generating knowledge about disparities and testing interventions that can narrow gaps in prevention, care delivery, outcomes, and survivorship.
15) What kinds of organizations are eligible to apply?
Eligibility is broad and includes many types of organizations capable of operating clinical research programs in community settings. Eligible applicants listed include: state, county, and local governments; special district governments; independent school districts; public and state-controlled and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with and without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities as permitted by the FOA's additional eligibility language.
16) Which federal agency sponsors this funding opportunity?
The sponsoring agency is the U.S. Department of Health and Human Services through the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI).
17) How many awards were anticipated?
The information provided states the FOA anticipated about 40 awards.
18) Is there an award ceiling (maximum funding amount) listed?
An "Award Ceiling" value is shown as 0 in the provided data. This typically indicates the ceiling was not specified in that summary field, rather than meaning there is no funding. Applicants are expected to consult the full FOA text for budget expectations, allowable costs, and any limits or justification requirements.
19) When was this opportunity created and when did it close?
The provided record shows the opportunity was created on June 13, 2018, with an original closing date of August 31, 2018.
20) What is the overall goal of the announcement in terms of national impact?
The overall aim is to build and sustain a nationwide community-based oncology research infrastructure that can run high-quality, NCI-aligned studies, increase access to trials and evidence generation in everyday care settings, and directly address participation gaps and cancer disparities through intentional, network-driven community research.
Browse more opportunities from the same category: Education, Health
Next opportunity: Computer and Network Systems (CNS): Core Programs
Previous opportunity: University Centers of Excellence in Developmental Disabilities Diversity Fellowships
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 18 016
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 18 016) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UG1 Clinical Trial Required) Apply for RFA CA 18 017 Funding Number: RFA CA 18 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required) Apply for RFA CA 18 015 Funding Number: RFA CA 18 015 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required) Apply for RFA CA 19 017 Funding Number: RFA CA 19 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) Apply for PAS 18 915 Funding Number: PAS 18 915 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed) Apply for RFA CA 19 016 Funding Number: RFA CA 19 016 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $1,600,000 |
| Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Training, and Outreach Capacity of the Geographic Management of Cancer Health Disparities Program (Admin Suppl - Clinical Trial Not Allowed) Apply for PA 18 934 Funding Number: PA 18 934 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Optional) Apply for RFA DA 19 008 Funding Number: RFA DA 19 008 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) Apply for PAR 19 032 Funding Number: PAR 19 032 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl Clinical Trial Not Allowed) Apply for PA 19 035 Funding Number: PA 19 035 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
| Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed) Apply for RFA CA 19 013 Funding Number: RFA CA 19 013 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $900,000 |
| HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional) Apply for RFA DA 19 024 Funding Number: RFA DA 19 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed) Apply for RFA DA 19 023 Funding Number: RFA DA 19 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) Apply for RFA CA 19 029 Funding Number: RFA CA 19 029 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) Apply for RFA CA 19 030 Funding Number: RFA CA 19 030 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 19 022 Funding Number: RFA CA 19 022 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 19 021 Funding Number: RFA CA 19 021 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 19 020 Funding Number: RFA CA 19 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 19 019 Funding Number: RFA CA 19 019 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 19 027 Funding Number: RFA CA 19 027 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 19 025 Funding Number: RFA CA 19 025 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 18 016", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.